Profile data is unavailable for this security.
About the company
Ocumension Therapeutics is a China-based holding company principally involved in the discovering, developing and commercializing ophthalmic therapies. Its main products include OT-401 (YUTIQ), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-301 (NCX 470), OT-101 and OT-202, among others. The Company conducts its businesses in the domestic market.
- Revenue in HKD (TTM)265.85m
- Net income in HKD-409.82m
- Incorporated2018
- Employees444.00
- LocationOcumension TherapeuticsNo. 1858 Yinzhongnan RoadGuoxiang Subdistrict, Wuzhong DistrictSUZHOU KY1-1205ChinaCHN
- Websitehttps://www.ocumension.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China Isotope & Radiation Corp | 7.16bn | 400.31m | 3.51bn | 3.11k | 8.76 | 0.6922 | 3.14 | 0.4897 | 1.25 | 1.25 | 22.38 | 15.83 | 0.5312 | 4.22 | 1.79 | 2,305,873.00 | 6.21 | 6.57 | 12.82 | 13.26 | 52.48 | 59.89 | 11.70 | 12.62 | 1.73 | -- | 0.1919 | 6.88 | 7.82 | 15.35 | -5.43 | 2.88 | -- | 2.92 |
| Biocytogen Pharmaceuticals Beijng Co Ltd | 773.61m | -413.24m | 3.51bn | 1.07k | -- | 4.14 | -- | 4.53 | -1.04 | -1.04 | 1.94 | 2.12 | 0.2732 | 16.21 | 5.74 | 725,713.60 | -14.59 | -- | -18.88 | -- | 70.59 | -- | -53.42 | -- | 1.24 | -21.30 | 0.4077 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
| CARsgen Therapeutics Holdings Ltd | 0.00 | -806.94m | 3.56bn | 516.00 | -- | 1.83 | -- | -- | -1.45 | -1.45 | 0.00 | 3.38 | 0.00 | -- | -- | 0.00 | -29.79 | -- | -32.14 | -- | -- | -- | -- | -- | 9.54 | -- | 0.0452 | -- | -- | -- | 16.19 | -- | -- | -- |
| CK Life Sciences Intl (Holdings) Inc | 5.32bn | 17.25m | 3.94bn | 1.93k | 229.05 | 0.9406 | 34.76 | 0.7403 | 0.0018 | 0.0018 | 0.5538 | 0.4359 | 0.4728 | 2.96 | 4.74 | 2,755,038.00 | 0.1532 | 1.11 | 0.211 | 1.43 | 30.76 | 30.52 | 0.3241 | 2.42 | 0.8512 | 0.8796 | 0.5861 | 59.00 | 0.8936 | 0.3407 | -86.93 | -42.01 | 0.2784 | -- |
| Jiangsu Recbio Technology Co Ltd | 0.00 | -617.19m | 4.44bn | 472.00 | -- | 3.81 | -- | -- | -1.28 | -1.28 | 0.00 | 2.41 | 0.00 | -- | -- | 0.00 | -25.47 | -- | -30.68 | -- | -- | -- | -- | -- | 2.33 | -- | 0.378 | -- | -- | -- | 20.86 | -- | -- | -- |
| Consun Pharmaceutical Group Ltd | 2.79bn | 846.58m | 4.94bn | 3.13k | 5.74 | 1.26 | 5.29 | 1.77 | 1.06 | 1.06 | 3.50 | 4.83 | 0.4981 | 2.08 | 9.10 | 893,815.30 | 15.13 | 12.04 | 22.57 | 19.25 | 74.19 | 74.55 | 30.37 | 24.89 | 2.62 | -- | 0.1155 | 41.53 | 10.71 | 7.03 | 14.88 | 11.01 | -- | 18.43 |
| Ocumension Therapeutics | 265.85m | -409.82m | 4.97bn | 444.00 | -- | 1.57 | -- | 18.71 | -0.6316 | -0.6316 | 0.4095 | 4.56 | 0.078 | 3.61 | 2.12 | 598,764.60 | -12.03 | -38.78 | -13.21 | -41.47 | 58.60 | 62.30 | -154.16 | -975.82 | 3.72 | -- | 0.0451 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
| Alphamab Oncology | 236.08m | -227.25m | 5.01bn | 435.00 | -- | 2.78 | -- | 21.21 | -0.2363 | -0.2363 | 0.2459 | 1.87 | 0.1028 | 0.7705 | 19.34 | 542,704.00 | -9.90 | -18.72 | -11.69 | -21.94 | 74.75 | -- | -96.26 | -415.55 | 5.55 | -- | 0.1333 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
| Microport NeuroTech Ltd | -100.00bn | -100.00bn | 5.20bn | 571.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 21.61 | -- | 768.73 | -- | -- | -- |
| Shandong Boan Biotechnology Co Ltd | 667.02m | -128.82m | 5.22bn | 813.00 | -- | 3.66 | -- | 7.82 | -0.2529 | -0.2529 | 1.31 | 2.80 | 0.2732 | 1.35 | 2.53 | 820,436.90 | -5.28 | -- | -7.02 | -- | 66.16 | -- | -19.31 | -- | 0.8383 | -7.47 | 0.2491 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | -100.00bn | -100.00bn | 5.26bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -28.25 | -- | 5.82 | -- | -- | -- |
| Ascentage Pharma Group International | 239.54m | -998.84m | 5.34bn | 583.00 | -- | 81.90 | -- | 22.29 | -3.53 | -3.53 | 0.8485 | 0.2247 | 0.0833 | 2.38 | 2.22 | 410,875.00 | -34.73 | -44.93 | -52.82 | -57.04 | 86.24 | 87.68 | -417.02 | -976.10 | 1.42 | -15.03 | 0.9622 | -- | 5.85 | 100.76 | -4.84 | -- | 2.82 | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -269.07m | 5.47bn | 133.00 | -- | 4.96 | -- | -- | -1.34 | -1.34 | 0.00 | 5.44 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 6.41 | -- | 0.0185 | -- | -- | -- | 65.62 | -- | -- | -- |
| Qyuns Therapeutics Co Ltd | 0.00 | -513.13m | 5.69bn | 323.00 | -- | 13.28 | -- | -- | -2.31 | -2.31 | 0.00 | 1.93 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -64.02 | 0.4436 | -- | -- | -- | 27.45 | -- | -- | -- |
| Sihuan Pharmaceutical Holdings Group Ltd | 2.01bn | -58.29m | 5.69bn | 2.87k | -- | 1.19 | -- | 2.83 | -0.0063 | -0.0063 | 0.216 | 0.5126 | 0.1572 | 0.8101 | 4.72 | 699,054.30 | -2.18 | -6.85 | -3.34 | -9.10 | 69.64 | 75.81 | -13.85 | -36.23 | 1.35 | -2.63 | 0.1863 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
| New Horizon Health Ltd | 1.47bn | 119.37m | 6.47bn | 1.04k | 59.20 | 2.01 | 41.64 | 4.40 | 0.2389 | 0.2389 | 3.22 | 7.04 | 0.4536 | 2.16 | 2.08 | 1,673,916.00 | 3.67 | -- | 3.99 | -- | 88.74 | -- | 8.10 | -- | 10.50 | -- | 0.1305 | -- | 259.54 | -- | 97.40 | -- | -- | -- |
Data as of May 06 2024. Currency figures normalised to Ocumension Therapeutics's reporting currency: Hong Kong Dollar HKD
16.30%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Temasek Holdings Pte Ltd. (Investment Management)as of 30 Jun 2023 | 54.17m | 7.79% |
| Capital Research & Management Co. (World Investors)as of 06 Dec 2023 | 34.37m | 4.94% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 9.36m | 1.35% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2024 | 3.97m | 0.57% |
| FIL Investment Management (Hong Kong) Ltd.as of 31 Mar 2024 | 2.87m | 0.41% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 2.36m | 0.34% |
| UBS Asset Management (Hong Kong) Ltd.as of 31 Jan 2024 | 2.04m | 0.29% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 1.89m | 0.27% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 1.41m | 0.20% |
| E Fund Management Co., Ltd.as of 30 Jun 2023 | 937.96k | 0.14% |
More ▼
Data from 31 Dec 2023 - 02 May 2024Source: FactSet Research Systems Inc.
